| Dr Michelle Bleynat Vessely, MD | |
|
6485 Sw Borland Rd Ste B, Tualatin, OR 97062-9762 | |
| (503) 692-1190 | |
| (503) 692-7017 |
| Full Name | Dr Michelle Bleynat Vessely |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 36 Years |
| Location | 6485 Sw Borland Rd Ste B, Tualatin, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851514343 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Caldwell Memorial Hospital | Lenoir, NC | Hospital |
| Berkshire Medical Center | Pittsfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Berkshire Faculty Services Inc | 8224068424 | 222 |
| Caldwell Memorial Hospital Inc | 5395646970 | 150 |
News Archive
A protein-sugar molecule, CD99, occurs more frequently than normal on stem cells responsible for blood cancers, including acute myeloid leukemia (AML) and the related myelodysplastic syndromes.
Researchers at MIT and Boston Children's Hospital have published a report today in the journal Nature Materials that provides a better understanding of the body's immune responses to the materials used in implanted medical devices.
State Medicaid and other health programs have fallen under the axe or been moved onto the chopping block this week.
Researchers at Virginia Commonwealth University's Massey Cancer Center have documented a novel form of resistance in leukemia cells to an anti-cancer drug, which could help scientists develop new strategies for treating the disease.
› Verified 7 days ago
| Entity Name | Berkshire Ear, Nose, Throat And Audiological Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588772396 PECOS PAC ID: 4981517299 Enrollment ID: O20031111000736 |
News Archive
A protein-sugar molecule, CD99, occurs more frequently than normal on stem cells responsible for blood cancers, including acute myeloid leukemia (AML) and the related myelodysplastic syndromes.
Researchers at MIT and Boston Children's Hospital have published a report today in the journal Nature Materials that provides a better understanding of the body's immune responses to the materials used in implanted medical devices.
State Medicaid and other health programs have fallen under the axe or been moved onto the chopping block this week.
Researchers at Virginia Commonwealth University's Massey Cancer Center have documented a novel form of resistance in leukemia cells to an anti-cancer drug, which could help scientists develop new strategies for treating the disease.
› Verified 7 days ago
| Entity Name | Berkshire Faculty Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548212939 PECOS PAC ID: 8224068424 Enrollment ID: O20050817001122 |
News Archive
A protein-sugar molecule, CD99, occurs more frequently than normal on stem cells responsible for blood cancers, including acute myeloid leukemia (AML) and the related myelodysplastic syndromes.
Researchers at MIT and Boston Children's Hospital have published a report today in the journal Nature Materials that provides a better understanding of the body's immune responses to the materials used in implanted medical devices.
State Medicaid and other health programs have fallen under the axe or been moved onto the chopping block this week.
Researchers at Virginia Commonwealth University's Massey Cancer Center have documented a novel form of resistance in leukemia cells to an anti-cancer drug, which could help scientists develop new strategies for treating the disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Bleynat Vessely, MD 6485 Sw Borland Rd Ste C, Tualatin, OR 97062-9762 Ph: (503) 692-1190 | Dr Michelle Bleynat Vessely, MD 6485 Sw Borland Rd Ste B, Tualatin, OR 97062-9762 Ph: (503) 692-1190 |
News Archive
A protein-sugar molecule, CD99, occurs more frequently than normal on stem cells responsible for blood cancers, including acute myeloid leukemia (AML) and the related myelodysplastic syndromes.
Researchers at MIT and Boston Children's Hospital have published a report today in the journal Nature Materials that provides a better understanding of the body's immune responses to the materials used in implanted medical devices.
State Medicaid and other health programs have fallen under the axe or been moved onto the chopping block this week.
Researchers at Virginia Commonwealth University's Massey Cancer Center have documented a novel form of resistance in leukemia cells to an anti-cancer drug, which could help scientists develop new strategies for treating the disease.
› Verified 7 days ago